Literature DB >> 15316210

Clinical, radiographic and functional predictors of pulmonary gas exchange impairment at moderate exercise in patients with sarcoidosis.

Walder G P Barros1, J Alberto Neder, Carlos A C Pereira, Luiz E Nery.   

Abstract

BACKGROUND: Pulmonary gas exchange impairment (GEI) is a common consequence of intrathoracic sarcoidosis presenting with important therapeutic and prognostic implications.
OBJECTIVE: To determine the role of clinical, radiographic and functional variables in predicting GEI during moderate exercise at the estimated lactate threshold (theta(L)) in patients with sarcoidosis.
METHODS: Fifty-four outpatients (29 females) with biopsy-proven sarcoidosis had clinical evaluation (baseline dyspnea index), lung function tests and an incremental cardiopulmonary exercise test with theta(L) estimation. On a separate day, patients underwent a constant work rate test at theta(L) with assessment of arterial blood gas tensions.
RESULTS: There was no evidence of GEI [DeltaP (A - a) O(2)/VO(2) >20 mm Hg.l. min(-1)] in patients with radiographic stages 0-I (n = 13). In the remaining 41 patients, GEI was associated with more extensive radiographic involvement and reduced diffusing capacity of the lung for carbon monoxide (DL(CO)), forced expiratory volume in 1 s, total lung capacity and forced vital capacity (% predicted;p < 0.05); baseline dyspnea index and resting arterial blood gas tensions, in contrast, were not significantly related to GEI. DL(CO) correlated best with GEI. The negative predictive value of DL(CO) >70% predicted (absent-to-mild impairment) was 91.3% (sensitivity = 81.8%) and the positive predictive value of DL(CO) </=50% predicted (severe impairment) was 83.3% (specificity = 96.6%, likelihood ratio = 13.35). There was no improvement in diagnostic accuracy when other physiological tests were added to DL(CO). These results were consistent with those found in a multiple logistic regression analysis with GEI as the dependent variable (p < 0.01).
CONCLUSIONS: Conventional chest radiography and DL(CO) measurements suffice to estimate the individual risk of GEI at moderate exercise in patients with sarcoidosis. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 15316210     DOI: 10.1159/000079641

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  9 in total

1.  Spirometry, cardiopulmonary exercise testing and the six-minute walk test results in sarcoidosis patients.

Authors:  Arda Kiani; Alireza Eslaminejad; Mohsen Shafeipour; Fatemeh Razavi; Seyyed Reza Seyyedi; Babak Sharif-Kashani; Habib Emami; Mehrdad Bakhshayesh-Karam; Atefeh Abedini
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

Review 2.  Patient reported outcome measures (PROMs) in sarcoidosis.

Authors:  Rikke Flor Thunold; Anders Løkke; Adam Langballe Cohen; Hilberg Ole; Elisabeth Bendstrup
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

3.  Comparison between cardiopulmonary exercise testing parameters and computed tomography findings in patients with thoracic sarcoidosis.

Authors:  Agnaldo José Lopes; Sara Lucia Silveira de Menezes; Cristina Márcia Dias; Juliana Flávia de Oliveira; Míriam Raquel Meira Mainenti; Fernando Silva Guimarães
Journal:  Lung       Date:  2011-08-20       Impact factor: 2.584

4.  Oxygen desaturation during a 6-minute walk test as a predictor of maximal exercise-induced gas exchange abnormalities in sarcoidosis.

Authors:  Cecile Chenivesse; Sarah Boulanger; Carole Langlois; Lidwine Wemeau-Stervinou; Thierry Perez; Benoit Wallaert
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

5.  Is there an added value of cardiopulmonary exercise testing in sarcoidosis patients?

Authors:  Rik G J Marcellis; Antoine F Lenssen; Geeuwke J de Vries; Robert P Baughman; Chris P van der Grinten; Johny A Verschakelen; Jolanda De Vries; Marjolein Drent
Journal:  Lung       Date:  2012-11-09       Impact factor: 2.584

6.  Reduction of exercise capacity in sarcoidosis in relation to disease severity.

Authors:  Anastasios Kallianos; Paul Zarogoulidis; Fotini Ampatzoglou; Georgia Trakada; Elias Gialafos; Georgia Pitsiou; Athanasia Pataka; Lemonia Veletza; Konstantinos Zarogoulidis; Wolfgang Hohenforst-Schmidt; Dimitris Petridis; Ioannis Kioumis; Aggeliki Rapti
Journal:  Patient Prefer Adherence       Date:  2015-08-18       Impact factor: 2.711

Review 7.  Is it time to scrap Scadding and adopt computed tomography for initial evaluation of sarcoidosis?

Authors:  Andrew Levy; Nabeel Hamzeh; Lisa A Maier
Journal:  F1000Res       Date:  2018-05-16

Review 8.  Catch the rainbow: Prognostic factor of sarcoidosis.

Authors:  Senol Kobak
Journal:  Lung India       Date:  2020 Sep-Oct

9.  Cardiopulmonary exercise testing variables as predictors of long-term outcome in thoracic sarcoidosis.

Authors:  A J Lopes; S L S Menezes; C M Dias; J F Oliveira; M R M Mainenti; F S Guimarães
Journal:  Braz J Med Biol Res       Date:  2012-02-16       Impact factor: 2.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.